Skip to main navigation

1.866.648.2767

info@tabularasahealthcare.com

Investors
mobilemenu

Investors - Investor News

Investors - Investor News

Keyword Search

Year

Houston Methodist Selects Tabula Rasa HealthCare’s DoseMe For System-wide Precision Dosing Technology

13 Jun 2019

Tabula Rasa HealthCare’s Dr. Sandra Leal is President-elect American Pharmacists Association

10 Jun 2019

Tabula Rasa HealthCare’s DoseMe Signs 3-Year Agreement with Portugal’s National Health Service

06 Jun 2019

Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences

22 May 2019

TRHC’s Capstone Performance Systems Gains New Clients and Expands Services in 1Q19

14 May 2019

Tabula Rasa HealthCare Announces First Quarter 2019 Operating Results

08 May 2019

CMS’ New Value-Based Payment Program is a Catalyst for Tabula Rasa HealthCare

25 Apr 2019

Tabula Rasa HealthCare to Announce First Quarter 2019 Operating Results and Host Conference Call on Wednesday, May 8, 2019

24 Apr 2019

Tabula Rasa HealthCare Continues Growth Trajectory by Expanding Integrated Services in PACE

22 Apr 2019

Prominent Arkansas Health Plan Partners with Tabula Rasa Healthcare’s PrescribeWellness to Improve Quality & Performance Outcomes for its Members

11 Apr 2019

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Investor Relations

Overview
Investor News
Events & Presentations
Stock Information
Corporate Governance
Financial Information
Investor Resources

IR CONTACT

Frank Sparacino

(866) 648-2767

fsparacino@trhc.com

RECEIVE E-MAIL ALERTS

Stay up to date on the latest Tabula Rasa HealthCare (TRHC) news.

Contact Us

1.866.648.2767

info@tabularasahealthcare.com

228 Strawbridge Drive
Moorestown NJ 08057

Careers

We are looking for individuals that can grow with our company. We offer a comprehensive benefits package, along with competitive compensation. Learn more today by clicking below.

Learn more >

©2020 Tabula Rasa Healthcare Legal | Privacy | Contact Us